EVALUATION OF SERUM TRYPSIN INHIBITOR ACTIVITY IN THE DETECTION OF MALIGNANT DISEASE
1964

Serum Trypsin Inhibitor Activity in Detecting Cancer

Sample size: 1043 publication Evidence: low

Author Information

Author(s): J. H. KEMP, J. M. JOHNSTONE

Primary Institution: Department of Pathology, Grimsby General Hospital

Hypothesis

Can serum trypsin inhibitor activity serve as a reliable screening test for malignant disease?

Conclusion

The study found that while serum trypsin inhibitor activity is low in normal individuals, it is not a reliable screening test for malignant disease.

Supporting Evidence

  • The study included 1043 individuals to assess serum trypsin inhibitor activity.
  • Normal individuals showed low serum trypsin inhibitor activity.
  • High serum trypsin inhibitor activity was noted in certain non-malignant conditions.
  • The test was not regularly raised in cases of malignant disease.

Takeaway

This study looked at a blood test to see if it could help find cancer. It found that while the test can show some signs of disease, it's not good enough to use all the time.

Methodology

The study estimated serum trypsin inhibitor activity using a specific substrate, benzoyl-l-arginine amide hydrochloride, in a large sample of individuals.

Limitations

The test fails as a satisfactory screening test for malignant disease due to low specificity and false positives in certain conditions.

Participant Demographics

Participants included hospital inpatients and outpatients, with a mix of normal and various disease conditions.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication